Status
Conditions
Treatments
About
The purpose of this study is to determine how many HIV-infected patients continue taking ritonavir/indinavir combination after having taken indinavir three times a day as part of their anti-HIV drug therapy. This study also examines the safety and effectiveness of the ritonavir/indinavir combination.
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria
Patients must have:
Exclusion Criteria
Co-existing Condition:
Patients with any of the following symptoms or conditions are excluded:
Any condition that in the opinion of the investigator may obscure proper observation of the safety or activity of the treatment regimens used in this study.
Concurrent Medication:
Excluded:
Patients with the following prior conditions are excluded:
Prior Medication:
Excluded:
Prior treatment with ritonavir.
Risk Behavior:
Excluded:
History of active substance abuse (i.e., recreational drugs or alcohol).
Included:
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal